Plain-English translation of NCT07608848 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
Australia
Phase
Safety & dosing
Sponsor
Integrated Haematology and Oncology Network
Enrollment target
~20 participants
Started
May 2026
Primary completion
May 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amma P Owusu, RN BSc MN
Integrated Hematology Oncology Network (Icon Group)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.